MedPath

AL-611

Generic Name
AL-611

A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus Infection

Phase 1
Terminated
Conditions
Hepatitis C
Interventions
Drug: Placebo
First Posted Date
2017-08-18
Last Posted Date
2017-10-25
Lead Sponsor
Alios Biopharma Inc.
Target Recruit Count
24
Registration Number
NCT03253471
Locations
🇧🇪

SGS Life Sciences, Antwerp, Belgium

© Copyright 2025. All Rights Reserved by MedPath